A new trading day began on Monday, with uniQure N.V (NASDAQ: QURE) stock price up 19.43% from the previous day of trading, before settling in for the closing price of $5.97. QURE’s price has ranged from $3.73 to $11.35 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 302.35%. Meanwhile, its annual earnings per share averaged 36.74%. With a float of $42.67 million, this company’s outstanding shares have now reached $48.74 million.
Let’s determine the extent of company efficiency that accounts for 480 employees. In terms of profitability, gross margin is -11.39%, operating margin of -716.18%, and the pretax margin is -821.68%.
uniQure N.V (QURE) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of uniQure N.V is 12.45%, while institutional ownership is 75.06%. The most recent insider transaction that took place on Jun 26 ’24, was worth 6,309. In this transaction Chief Medical Officer of this company sold 1,447 shares at a rate of $4.36, taking the stock ownership to the 115,253 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Chief Operating Officer sold 2,936 for $4.81, making the entire transaction worth $14,122. This insider now owns 115,707 shares in total.
uniQure N.V (QURE) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.41 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.76 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.74% per share during the next fiscal year.
uniQure N.V (NASDAQ: QURE) Trading Performance Indicators
Here are uniQure N.V’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.96, a number that is poised to hit -0.66 in the next quarter and is forecasted to reach -3.06 in one year’s time.
Technical Analysis of uniQure N.V (QURE)
Looking closely at uniQure N.V (NASDAQ: QURE), its last 5-days average volume was 0.81 million, which is a drop from its year-to-date volume of 1.37 million. As of the previous 9 days, the stock’s Stochastic %D was 59.68%. Additionally, its Average True Range was 0.53.
During the past 100 days, uniQure N.V’s (QURE) raw stochastic average was set at 48.16%, which indicates a significant decrease from 81.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.11% in the past 14 days, which was higher than the 84.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.00, while its 200-day Moving Average is $5.77. However, in the short run, uniQure N.V’s stock first resistance to watch stands at $7.61. Second resistance stands at $8.09. The third major resistance level sits at $8.69. If the price goes on to break the first support level at $6.53, it is likely to go to the next support level at $5.93. Now, if the price goes above the second support level, the third support stands at $5.45.
uniQure N.V (NASDAQ: QURE) Key Stats
With a market capitalization of 344.66 million, the company has a total of 48,743K Shares Outstanding. Currently, annual sales are 15,840 K while annual income is -308,480 K. The company’s previous quarter sales were 2,290 K while its latest quarter income was -44,380 K.
